Symbiotec Pharmalab

What they make

1 input Symbiotec Pharmalab supplies

Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.

Intelligence

What's known

Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.

• Did you know2024

  Steroidal pharmaceutical API synthesis — including the budesonide and fluticasone that go into asthma inhalers — begins from plant-derived phytosterols (sitosterol, stigmasterol, campesterol) extracted from soybean oil deodorizer distillate (SODD) — a byproduct of soybean oil refining. Soybean phytosterols are separated from SODD by crystallization or molecular distillation; the phytosterol mixture is then converted to androstenedione (AD) or androstadienedione (ADD) intermediates by microbial side chain cleavage, and ultimately built up synthetically to corticosteroid APIs like budesonide. The agricultural supply chain for soybeans therefore determines pharmaceutical steroid API availability: a severe US or South American soybean crop failure (drought, disease, trade disruption) would reduce SODD byproduct available for phytosterol extraction, tightening the steroid intermediate supply chain and ultimately raising generic inhalation drug prices. The soybean harvest in Mato Grosso, Brazil and in Iowa, USA each autumn is therefore an indirect input to the following year's inhalation drug supply and pricing — a connection entirely invisible to respiratory patients, physicians, and most pharmaceutical procurement officers.

  Symbiotec Pharmalab Pvt. Ltd. ↗

• Concentration2024

  Indian pharmaceutical manufacturers — Glenmark Life Sciences, Divi's Laboratories, Symbiotec, Cipla's API division, and a handful of others — collectively supply approximately 40-50% of global generic corticosteroid API (budesonide, fluticasone, beclomethasone) for inhalation drugs. When India imposed export controls on pharmaceutical starting materials and APIs in March 2020 at the start of the COVID-19 pandemic, multiple European and US generic drug manufacturers immediately faced steroid API supply uncertainty, because they had progressively moved API sourcing to India over two decades for cost reasons. The US FDA has since increased its monitoring of Indian API manufacturing sites and the FDA's drug shortage early warning system explicitly tracks Indian API dependence for essential medicines including inhaled corticosteroids. A geopolitical crisis between India and the US/EU or a major Indian pharmaceutical manufacturing disruption (natural disaster, power grid failure, regulatory shutdown) would cause generic respiratory drug shortages affecting hundreds of millions of asthma and COPD patients globally — a pharmaceutical supply chain concentration risk comparable to semiconductor supply chain concentration in Taiwan.

  US Food and Drug Administration ↗

• Origin2024

  Symbiotec Pharmalab is based in Indore, Madhya Pradesh — one of India's primary pharmaceutical API manufacturing hubs, alongside Hyderabad (Telangana) and Ahmedabad (Gujarat). Indore's pharmaceutical clustering emerged from the convergence of the Madhya Pradesh government's industrial incentives, proximity to soybean cultivation in the Malwa plateau (a key source of phytosterol raw material for steroid APIs), and concentration of chemical engineering expertise from Indore's technical colleges. Symbiotec's specialization in steroidal APIs places it at the confluence of India's agricultural economy (soybean phytosterols), India's generic pharmaceutical manufacturing scale, and the global inhalation drug supply chain. The Indian government's Production-Linked Incentive (PLI) scheme for key starting materials and APIs — explicitly targeting corticosteroids as a category — has reinforced domestic investment in steroid API capacity, positioning companies like Symbiotec as strategic industrial assets in India's pharmaceutical sovereignty agenda.

  Symbiotec Pharmalab Pvt. Ltd. ↗